You're reading the free version. Trader adds the live tape and alerts.
Start tracking
REGN Sale Disclosure
Ryan Arthur F · SEC Form 4 · Filed Jul 7, 2026
Sale
Calculated transaction value
$130.03K
Ryan Arthur F Director
REGN
Transaction date
Jul 2, 2026
Public filing date
Jul 7, 2026
Filing lag
Filed 5 days later
REGN daily price context
Close on/before transaction
$654.27
Jul 2, 2026
First close after public filing
$662.88
Jul 8, 2026
30-day return after filing
+16.48%
Through Aug 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 200 shares @ $650.15
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001187443-26-000010
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$130.03K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. REGN Current | Sale | Jul 2, 2026 | $130.03K |